Innate and adaptive immune basis of mental health effect on Alzheimer's disease progression
Abstract
Mental health has long been suspected to be highly associated with neurodegenerative disease, but it lacks experimental evidence to elaborate the link and immunological mechanism between them. In this work, we studied the progression of Alzheimers disease (AD) and its associated immune activity by using the transgenic mice under negative (depression) and positive (environmental enrichment, EE) mental health intervention. The tissue pathology, resident and peripheral immunity and behavioral characteristics were investigated. The transgenic mice undergoing depression treatment was featured with aggravated AD pathology, elevated activation of microglia in the brains, more abundance of Treg cells and cytotoxic T cells, and higher ratios of central memory T cells to effector memory T (TCM-to-TEM) cells in the peripheral blood and spleens. The EE treated mice were featured with alleviated AD pathology, reduced activation of microglia, less amounts of Treg and cytotoxic T cells and lower ratios of TCM-to-TEM cells. This study may provide strategies for immunity regulation and mental health intervention that benefit AD therapy. Significance statementMental health is suspected to regulate AD progression, but its validation in histology examination and the regulatory mechanism remains unclear. Here, we prove that both innate and adaptive immunity are playing important roles and mental health-immunity-AD progression forms a triad. More active microglia, Treg, and cytotoxic T cells, and higher TCM-to-TEM feature negative mental health and severer AD progress, and vice versa. The findings in adaptive immunity and the triad may inspire AD regulation.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Altered T cell reactivity to β-amyloid-related antigens in early Alzheimer's disease
Chiara Rickenbach, Anna Mallone, … Christoph Gericke·BrainPeer-reviewed·Apr 30, 2025
- Immune receptor LAG3 regulates microglia function duringAlzheimer's disease
Andrew T. Perl, Juan Wu, … Elizabeta Gjoneska·Neurobiology of DiseasePeer-reviewed·May 12, 2026
- The AppNL-G-F mouse model of Alzheimer's disease is refractory to regulatory T cell treatment
L. Yshii, L. Mascali, … A. Liston·bioRxiv·Mar 11, 2022
- Natural Microbial Enrichment Modulates Microglial States and Transcriptional Programs Relevant to Alzheimer's Disease
Mohamed Lala Bouali, Amir Mohamed Kezai, … Sébastien S. Hébert·Frontiers in ImmunologyPeer-reviewed·Aug 25, 2026
- Cytokine expression patterns predict suppression of vulnerable neural circuits in a mouse model of Alzheimer's disease
Dennis Chun Yin Chan, ChaeMin Kim, … Elizabeth A. Proctor·bioRxiv·Mar 17, 2024
- Modulation of Alzheimer's Disease Brain Pathology in Mice by Gut Bacterial Deletion: The Role of Il-17a and Microglial MyD88
Wenlin Hao, Qinghua Luo, … Yang Liu·bioRxiv·Dec 6, 2023